What is the CVR number of Europe Medical Solution ApS?

Europe Medical Solution ApS is registered with CVR / Virk under CVR 37203378.

What is the revenue of Europe Medical Solution ApS?

Europe Medical Solution ApS reported revenue of DKK 866K in 2024.

Who is the CEO of Europe Medical Solution ApS?

David Golshani is Chief Executive Officer of Europe Medical Solution ApS, in role since 2015.

Where is Europe Medical Solution ApS headquartered?

Europe Medical Solution ApS's registered address is Holmetoften 53.

Europe Medical Solution ApS

APSActive

CVR 37203378Holmetoften 53Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2015— employeeswww.emsfarma.com

Full Risika report

Revenue 2024

DKK 866K

+35% vs 2023

EBITDA margin

100.0%

+35% vs 2023

Equity ratio

81.3%

Financial strength

Net profit 2024

DKK 673K

+35% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK 866K	+35%
EBITDA	DKK 866K	+35%
Net profit	DKK 673K	+35%
Total assets	DKK 1,9M	+83%
Equity	DKK 1,6M	+76%
Employees	—	—

Item	2020	2021	2022	2023	2024
Revenue	169	272	488	642	866
Staff expenses	-0	-0	-0	-0	-0
EBITDA	169	272	488	642	866
Depreciation & amort.	-0	-0	-0	-0	-0
EBIT	169	272	488	642	866
Net financials	-12	-4	-9	-0	-2
Profit before tax	157	268	479	642	864
Tax	-0	-0	99	141	191
Net profit	157	268	380	500	673

Item	2020	2021	2022	2023	2024
Total assets	829	613	1.002	1.052	1.925
Equity	-257	10	390	891	1.564
Long-term debt	0	0	0	0	0
Short-term debt	1.086	603	611	161	361
Total debt	1.086	603	611	161	361

Name	Role	Member since
Current (1)
DG David Golshani Chief Executive Officer	Chief Executive Officer	2015

Shareholder	Type	Ownership	Votes	Since
Golshani Healthcare Corporate ApS	Company	100%	100%	2015

Person	Role here	Other companies
David Golshani	Chief Executive Officer	0 companies

Europe Medical Solution ApS

APSActive

CVR 37203378Holmetoften 53Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2015— employeeswww.emsfarma.com

Full Risika report

Revenue 2024

DKK 866K

+35% vs 2023

EBITDA margin

100.0%

+35% vs 2023

Equity ratio

81.3%

Financial strength

Net profit 2024

DKK 673K

+35% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK 866K	+35%
EBITDA	DKK 866K	+35%
Net profit	DKK 673K	+35%
Total assets	DKK 1,9M	+83%
Equity	DKK 1,6M	+76%
Employees	—	—